Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Samurai Virtual Training With Martial Artists Kevin Kearns & Hanshi Dave Kovar At Sharon Kleyne Talk Radio


Sharon Kleyne, Founder of Bio Logic Aqua® Research

Sharon Kleyne, Founder of Bio Logic Aqua® Research

Air Date: 20 July 2020

Guests: Dave Kovar, “the undisputed teacher of teacher” Martial Artist, Social Entrepreneur, health & fitness advocate, elite athlete, teacher, speaker and author, Oakland, California, Kevin Kearns, founder/CEO of Burn with Kearns and Beach Bod Transformation; All-star Conference Presenter for IDEA Boston, Massachusetts.

https://www.voiceamerica.com/episode/124671/the-mastery-mindsets-applying-samurai-wisdom-to-modern-living

Talk Radio VoiceAmerica World Talk Radio & Apple iTunes host Sharon Kleyne believes the mindfulness and martial arts physical training of Samurais is needed more than ever as the world battles that COVID-19 pandemic. Kleyne teaches that martial arts train the mind away from preoccupation with the self and can program the way we think. That is why Kleyne has welcomed guests like Qigong Grandmaster Dr. Effie Chow to the program several times, and that is why she has recently welcomed two martial arts instructors and masters, Kevin Kearns of Boston, Massachusetts and Hanshi Dave Kovar of Oakland, California. “Martial arts should be taught to all children, to all our warriors in boot camp and to all law enforcement people,” says Kleyne.

Kearns and Kovar agree and approach the coaching and instructing of the martial arts holistically. Kearns shares a poignant story about a longtime student of his who suffered from MS. One day, she said to him, “I know I can make it better because I can make it worse”. Kearns says he always thinks of that profound expression of the power of the mind through participation in martial arts training.

Kovar works with more than 3,000 students at his schools throughout northern California. Known as “the undisputed teacher among teachers,” Kovar teaches what he calls his Mastery Mindsets. This is his application of Samurai wisdom to modern living; it teaches leadership and wisdom in all areas of life through virtual training.

In her Commentary, Global Health Olympics lifestyle founder Kleyne says of physical challenges, “You can train, you can beat it! Be proactive. Ask what you need to learn. Become inventors yourself at your own kitchen tables. Get back to work, back to school! We learned how to wear a seatbelt,” Kleyne recalls.

“On this show, I teach water,” Kleyne instructs. “You must drink a lot of water. Drink a full glass at a time for full absorption. The body makes the decisions, not you. It’s the spit, the carrier.” Kleyne reveals. “Why is it the spit? When you were a baby and you came out of that womb and began to evaporate water like a sponge, the body began to evaporate living with the atmospheric water vapor. When you’re drinking your water by the glass, it gives it a chance to replenish the sponge of your life,” Kleyne continues.

“What happens with the spit in the oral cavity in the mouth, that tongue that has that saliva, a spit comes out when we’re talking sometimes. It doesn’t show sometimes. Sometimes you can see it if you’re standing in the sun,” Kleyne reveals. “If you happen to be carrying the virus, that spit comes out anyway from birth. That’s why you have a tone of voice of your own. The baby picks up a tone and what happens with your tone and voice—have you ever recognized somebody before you saw them by the tone of their voice? It’s that tone! If you didn’t have spit, there’s a very difficult challenge to getting a tone,” Kleyne says.

“It’s the spit,” Kleyne goes on. “The more you talk and the louder you get, the more spit! It touches something and if your fingertips touch it, you can contaminate around the organ of the eye. It’s the one organ of your body,” Kleyne teaches, “That is open to the rest of the world if that eyelid is open. It’s got a tear film with nature’s blessing that is 99% water. Your immunity strength that you’re learning now is to battle that war of contaminations. The body gives you those strengths, but you’ve got to learn to work with them.”

We come back to the need for better health education and new technology health hygiene habits and practices.

“You have to learn how to wear a mask,” says Kleyne. “I know it’s difficult for Americans, but we have to learn like other countries of the world long ago. We need to learn that you need to keep your hands sanitized; we need to realize that it’s the spit and so we need to wear a mask and teach each other why the mask is very important to protect others from spit and you from spit. And then you’ve understood that the eye is the carrier and immunity strength is in that tear film. Enjoy the fact that you’re learning!” encourages Kleyne.

Yes, enjoy learning. At the same time study the martial arts on line or in person. Learn to adapt and program your minds for optimum health. It will help everyone win the war against the virus and get people back in the gym, back to school and back to work!

LISTEN to the internationally syndicated The Power of Water® & Your Health sponsored by Nature’s Tears® EyeMist®, naturally pH balanced water technology for acid mantel protection, on VoiceAmerica World Talk Radio & Apple iTunes with producer and host Sharon Kleyne and program director Rose Hong of Global Dragon TV. This program features Kevin Kearns and Hanshi Dave Kovar.

Follow this link: https://www.voiceamerica.com/episode/124671/the-mastery-mindsets-applying-samurai-wisdom-to-modern-living

Some recent Sharon Kleyne talk radio programs feature:

Dr. Mark Mincolla, Ph.D. & Kevin Kearns

https://www.voiceamerica.com/episode/124442/anti-inflammatory-diet

Dr. Anita Marshall https://www.voiceamerica.com/episode/124294/herbal-alternatives-to-drugs-and-covid-19-prevention-and-treatments

Philip Paden, M.D. https://www.voiceamerica.com/episode/124183/immunity-protector-with-natures-tears-eyemist

Kevin Kearns & Steven Aithwaite

https://www.voiceamerica.com/episode/124035/earths-human-mission-a-healthier-planet

Mary Carolyn, Nutritionist https://www.voiceamerica.com/episode/123934/natural-immune-boosters

Kevin Kearns & Brandon Foster https://www.voiceamerica.com/episode/123823/strengthening-childrens-immune-system-through-fitness

Dr. Gerald Pollack, Ph.D. https://www.voiceamerica.com/episode/123059/the-fourth-phase-of-water

If you would like to watch a brief, entertaining educational film that demonstrates the application of the new Dry Eye Solution® technology Nature’s Tears® EyeMist®, sponsor of Sharon Kleyne’s talk radio program, go here: https://www.youtube.com/watch?v=l0gOr8TB45U

Share article on social media or email:

Jericho Project Wins Van Ameringen Grant to Expand Mental Health Care for Formerly Homeless Individuals


News Image

Tori Lyon, Jericho Project CEO

As the COVID health crisis has demonstrated, mental and physical wellness are closely linked and can be powerful forces in getting a person back on their feet. — Jericho Project CEO Tori Lyon

Jericho Project, a nonprofit leader ending homelessness at its roots, has been awarded a grant of $270,000 from the van Ameringen Foundation to expand the Jericho Therapy Program (JTP) delivering vital mental health services to formerly homeless individuals.

“Mental health is key to helping our clients cope with the trauma of homelessness, regain stability and move on to more fulfilling lives. As the COVID health crisis has demonstrated, mental and physical wellness are closely linked and can be powerful forces in getting a person back on their feet,” said Jericho Project CEO Tori Lyon.

“Jericho Project’s bold initiative is bringing much-needed mental health support to vulnerable New Yorkers. We know that this kind of preventive care is vastly more effective for people – and less taxing on the city – than emergency care,” said Hugh Hogan, Executive Director, the van Ameringen Foundation. The Foundation is an urban leader in early intervention, advocacy and increased accessibility of mental health services for people and communities with limited financial means and opportunities.

Jericho annually serves 2,500 adults, children, veterans and young, largely LGBTQ, adults through access to housing and comprehensive services, such as employment and training, wellness and family reunification.

Mental health services enabled by the grant will include short- and long-term counseling, evidenced-based treatments and group facilitations such as bereavement. This on-site support is especially important during social distancing, enabling Jericho clients to access the care they need by reducing referrals and unnecessary travel to outside providers.

The three-year grant will allow the addition of a full-time Licensed Clinical Social Worker (LCSW) to join the JTP Clinical Therapist currently serving veterans and young LGBTQ adults. Initially, this individual will focus on four programs for other Jericho clients living at three supportive housing residences and in separate supportive apartments throughout the city.

These professionals will operate as part of Jericho’s clinically-trained mental wellness team that also includes three LCSW supervisors, four Licensed Mental Health Clinician (LMSW) supervisors,  and twelve program staff with a Master’s Degree in Social Work. Jericho follows best practices with mandatory clinical staff trainings on advancements in and changes to the therapeutic landscape.

This is consistent with Jericho’s pursuit of measurable outcomes for its clients. Overall, Jericho has nine supportive housing residences in New York, offering comprehensive counseling services that have enabled 95% of residents maintain stable housing, and 90% of those affected by substance abuse to maintain their sobriety.

About the van Ameringen Foundation: From its inception in 1950, the Foundation has funded prevention, education, and direct care in the mental health field, as well as advocacy efforts to achieve systems change locally and nationally. The emphasis continues to be on assisting people and communities with limited resources and opportunities to access preventive, early intervention and effective mental health treatment.

https://www.vanamfound.org

About Jericho Project: Inspired by the belief that transformation can occur in every individual, Jericho Project steadfastly works to end homelessness at its roots by creating a community that inspires individual change, fosters sustainable independence, and motivates men and women to reach their greatest potential. For 37 years, Jericho has provided supportive housing and counseling services to thousands of individuals experiencing chronic homelessness and substance abuse.

Jericho Project employs rigorous fiscal discipline and works with valued public-private partnerships and a foundation of dedicated donors, to advance its mission. Jericho’s housing and extended services cost $13,000 per person annually, compared to $32,000 for a single shelter, $50,000 for a family shelter, and $168,000 for a jail cell annually.

http://www.jerichoproject.org | @jerichoproject1983

Share article on social media or email:

U.S. Army Desert Storm Veteran, Community Leader Brings COVID-19 Protection Tech to Unforgotten Heroes


AP & Associates, LLC, chaired by Phoenix-based businessman and nonprofit leader Alan “AP” Powell, is excited to announce a partnership with Noral Clean Technologies to bring the state-of-the-art BioProtect System to the Travis L. Williams American Legion Post 65, which serves veterans in South Phoenix’s 85040 zip code, one of the most vulnerable communities in the state.

Powell, a serial entrepreneur, Gulf War Veteran, philanthropist and a renowned strategic consultant, most recently launched the nation’s largest COVID-19 testing site, a free drive-thru, at South Mountain Community College through his nonprofit, the HeroZona Foundation. The location was specifically chosen to ensure that veterans and the local community have access to much needed resources that can help them stay protected against the virus.

“Post 65 works hard every day to ensure that the military heroes who reside there are supported,” Powell says. “By partnering with Noral Clean Technologies and bringing this crucial sanitizing service to the facility, we are helping to keep all of the members safe from coronavirus.”

The BioProtect System by Noral Clean Technologies is a proven antimicrobial solution treatment that creates a microscopic barrier on both porous and non-porous surfaces for up to three months. The coating forms a shield of molecular spikes which carry a positive charge that attract negatively charged bacteria. Once attracted, the spikes pierce the cell and rupture its membrane, causing the micro-organism to die. The spray is colorless, odorless, environmentally responsible and nontoxic, making it safe to use in high traffic areas. BioProtect can be used to safeguard against coronavirus, MRSA, ringworm, influenza, HIV and more.

“Three months of protection from coronavirus and other harmful organisms will help to keep the legion safe and its members and guests healthy,” says J. Glynn Gross, CEO of Noral Clean Technologies. “We are honored to have been entrusted by AP and the American Legion to protect these heroes.”

Outside of the spray technology, the post will also be given BioProtect’s hand purifier that provides six hours of protection against germs, after just one application. Similar to the antimicrobial solution, the alcohol-free formula creates a protective barrier on the skin, with aloe vera infusion to hydrate.

Noral Clean Technologies with the help of AP & Associates, LLC, will be performing its patented and FDA and EPA-approved BioProtectUS system to provide three months of protection at the Post in August. Legionnaires will also be provided with the state-of-the-art hand purifier to keep themselves safe once the service is concluded.

“Since closing due to the pandemic, myself and the other Post officers have not felt ready to reopen to the public yet with the exception of our kitchen for takeout meals,” says Jarvis Reddick, Post Commander and retired U.S. Air Force veteran. “With the help of AP & Associates, and Noral Clean Technologies, we are hoping to welcome the veteran community back soon in the safest and healthiest way.”

Corporate businesses and residential communities interested in learning more about Noral Clean Technologies’ BioProtect services can visit noralcleantech.com or call 888-846-4356.

For more information about AP & Associates, LLC, the Travis L. Williams American Legion Post 65 and all its programs, visit apscottsdale.com and twilliamspost65.org.

About AP & Associates LLC

AP & Associates LLC is a strategic alliances firm with specific expertise in multicultural and veteran initiatives. Through the development and creation of strategic partnerships AP & Associates has positioned itself as an expert in the art of company, customer and revenue acquisition. AP & Associates LLC has created strategic alliances with Fortune 500 companies, venture capital firms and private equity to bridge the gap between mainstream and urban customers to clients generating top flight results, capable of raising the monies, introducing strategic relationships and driving customer and revenue acquisition. For more information, visit http://www.apandassociatesllc.com.

Share article on social media or email:

NeoTract Designates Dr. Gerald Yoon as UroLift® Center of Excellence


News Image

“We are pleased to recognize Dr. Gerald Yoon as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Gerald Yoon, M.D., of PIH Urology, in Whittier, CA, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Yoon has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are pleased to recognize Dr. Gerald Yoon as a UroLift Center of Excellence for his commitment to providing consistent care to BPH patients using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “This achievement has helped many patients experience durable, long- term relief from the burdensome symptoms of BPH while preserving sexual function*1,2.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose.

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Elitac Wearables launches the BalanceBelt, a revolutionary wearable for people suffering from severe balance disorders


BalanceBelt

“Physiotherapy and other treatments currently available are insufficient for many patients with a severe loss of function”, Prof. Kingma explained. “But then we discovered that haptic feedback – vibrational feedback applied to the body – can help balance disorder patients find their balance again.”

Severe Bilateral Vestibular Loss (BVL) is a disorder in which the balance organs in the inner ears function very poorly or not at all. In these cases, the vestibular (balance) organs provide insufficient information for patients to control their body position in space, causing severe imbalance and difficulty walking. BVL inhibits patients from moving around independently and exercising, potentially leading to feelings of isolation and diminished health as a consequence. The prevalence of severe BVL in the general population has been estimated at a minimum of 81 in 100,000, affecting over 6 million people worldwide. In addition, more than 20% of people over 65 suffer from poor balance caused at least partly by a diminished functioning of the balance organs.

The BalanceBelt aids BVL patients by applying haptic feedback around the waist to improve their perception of body position. The concept was first invented and realised for daily use by Prof. Kingma, of Maastricht University (The Netherlands). “Physiotherapy and other treatments currently available are insufficient for many patients with a severe loss of function”, he explained. “But then we discovered that haptic feedback – vibrational feedback applied to the body – can help balance disorder patients find their balance again.”

Prof. Kingma and the Maastricht University Medical Centre+ (MUMC+) developed the first version of the BalanceBelt together with Maastricht Instruments. After the concept proved its effectiveness in patient trials in 2018, Elitac Wearables was invited to the project to optimise the product design and make it suitable for production at scale. The BalanceBelt contains several tiny vibration motors (tactors) and an accelerometer. It senses the direction the wearer is leaning toward and provides vibrational feedback to improve the perception of their body position. This feedback is interpreted by the wearer’s brain, allowing them to correct their posture and improve balance subconsciously. There is no need to pay conscious attention to the haptic feedback. The belt works stand-alone and can be used continuously for up to 16 hours a day.

Merijn Klarenbeek, co-founder and CEO of Elitac Wearables said, “We were really excited to join this project. This is a great example of a wearable where haptic feedback can deliver incredible added value, especially as the treatment alternatives for BVL are so limited. And we managed to improve the design so that the belt is lightweight and comfortable to wear, while being cost-effective to produce. The feedback from the patient trials was quite moving. Patients commented that the belt gave them back their independence and allowed them to enjoy their lives for the first time in a long while. Some of them even commented that they were able to get out of their wheelchairs and walk again.”

The BalanceBelt is available from today, via Elitac Wearables’ commercial partner Salesco. “We are very excited about making the BalanceBelt internationally available, so a wider range of patients can benefit from an improved quality of life.” Initially, the belt will be distributed via local distributors, BalanceBelt.net, and the Maastricht University Medical Centre+.

About Elitac Wearables

As experts on haptic feedback and the integration of textiles and electronics, Elitac Wearables collaborates with partners to develop wearables from idea to successful products. The company focuses on wearables that add real value and has developed several solutions for the medical, safety, defense and sports markets. By continuously investing in research, Elitac Wearables ensures that it stays ahead of new technological developments.

https://elitacwearables.com | LinkedIn | Twitter | Instagram | #BalanceBelt

For additional information or images, please contact:

Salesco

Phone: +45 494945000

E-mail: info@balancebelt.net

https://www.balancebelt.net/

Elitac Wearables

Dani van Weert, Marketing Communications Specialist

Phone: +31 (0)6 82050365

E-mail: d.vanweert@elitac.nl

Share article on social media or email:



R3 International Offering New Stem Cell Therapy for Neuropathy Program in Mexico


Stem Cell Therapy for Neuropathy in Mexico

Stem Cell Therapy for Neuropathy in Mexico (888) 988-0515

Traditional treatments for neuropathy pain with narcotics and other medications don’t address the real problem and have lots of side effects. Stem cell treatment on the other hand, is very safe and very effective!

R3 International is now offering a new stem cell therapy for neuropathy program in Mexico. The regenerative treatments involve up to 200 million stem cells and have been very effective at relieving neuropathic pain.

Peripheral neuropathy affects many millions of Individuals worldwide, and often leads to chronic, debilitating pain. It may occur as a result of diabetes, alcoholism, radiation, chemo or many other potential causes.

Stem cell and exosome therapy for neuropathy has achieved tremendous results at R3 International. Stem cells and exosomes are excellent at promoting nerve regeneration and new blood vessel formation.

According to R3 CEO David Greene, MD, MBA, “Patients lament the traditional pain medications they are offered for relief, which may lead to addiction or an overdose. The stem cell and exosome therapy offered at R3 International is safe and very effective for relief and helping patients be able to walk farther.”

Treatments at the clinic are outpatient, and involve anywhere from 30 million stem cells up to 200 million. The treatment starts at only $2975, with escorted transportation included from San Diego to the clinic and back. The patient concierge representative goes with the patient to the treatment as well.

The process starts with a free phone consultation with the R3 licensed, experienced stem cell doctor. Once treatment is scheduled, the R3 patient concierge assists with travel logistics.

In addition to the neuropathy stem cell program, R3 International also provides stem cell treatment in Mexico for COPD, kidney failure, autism, arthritis, diabetes, hepatitis, Lyme disease, MS, ALS, Alzheimers and more.

Call (888) 988-0515 to schedule the free phone consultation.

Share article on social media or email:

R3 International Now Including Exosomes with Stem Cell Therapy Program for Autism in Mexico


stem cells autism Mexico

Stem Cell and Exosome Therapy for Autism in Mexico (888) 988-0515

Our autism program includes first rate biologics with cell counts that are very high. Safety is paramount, and the lab’s safety standards exceed those of the FDA!

R3 International is now including exosomes with its stem cell therapy program in Mexico for autism. They have been shown to be an effective, safe option for autism patients.

Stem cell and exosome therapy for autism has shown excellent outcomes at R3 International in Tijuana, with the procedures performed by licensed, expert doctors. The doses of biologic are calculated based on the patient’s weight. Up to 200 million stem cells are included, along with over 100 billion exosomes.

Autism treatment with regenerative biologics has been very safe and each patient (and family) receives an escort from San Diego to the treatment clinic in Mexico. The autism stem cell treatment center is only twenty minutes from the San Diego International Airport.

According to R3 CEO David Greene, MD, MBA, “Our autism program includes first rate biologics with cell counts that are very high. Safety is paramount, and the lab’s safety standards exceed those of the FDA. We set the program up to be extremely cost effective with several options to make it convenient for patient families!”

There are multiple treatment options for autism patients including:

1. A one time visit with 30 or 50 million stem cells starting at $2975.

2. A 5 day stay with several treatments starting at $8975.

3. Several visits over a year period, all inclusive starting at $10,475.

The exosome part of the therapy includes billions of exosomes and is provided at no additional charge. Exosomes are derived from mesenchymal stem cells, and are amazing at cell to cell communication. Research has shown that exosomes are vital in the development of neural circuits, which can enhance the clinical outcomes for autism (Natl Acad Sci, 2019).

To get started with stem cell and exosome therapy for autism in Mexico, call R3 today at (888) 988-0515.

Share article on social media or email:

NeoTract Designates Dr. Marc Guttman as UroLift® Center of Excellence


News Image

“This designation recognizes Dr. Marc Guttman as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Marc Guttman, D.O., Naples Urology Associates in Naples, FL, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Guttman has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“This designation recognizes Dr. Marc Guttman as a UroLift Center of Excellence for his commitment to providing safe and effective treatment to patients with BPH,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “We are pleased to see the continued acceptance of the UroLift System as a standard of care treatment that may allow men to discontinue the use of BPH medications and improve their quality of life.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Kessler Foundation Reflects on 30th Anniversary of the ADA


ADA 30th anniversary logo

“The Foundation has invested more than $270 million in research to improve cognition and mobility for individuals of all ages with disabilities caused by neurological illness and injury,” said Rodger DeRose, president and CEO of Kessler Foundation.

As the Americans with Disabilities Act (ADA) turns 30, we celebrate the many ways that this groundbreaking legislation has helped people with disabilities strive for inclusion, paving the way for greater participation in the nation’s schools, communities and workplaces. Over the past 30 years, Kessler Foundation has conducted a broad scope of rehabilitation research and trained new generations of researchers to ensure that people with disabilities have the abilities they need to fully exercise their rights ensured by the ADA.

“The Foundation has invested more than $270 million in research to improve cognition and mobility for individuals of all ages with disabilities caused by neurological illness and injury,” said Rodger DeRose, president and CEO of Kessler Foundation. “Through our partnerships with universities, hospitals, government agencies, and the business community, we are also expanding the evidence base for new solutions for successfully transitioning people with disabilities to the workplace,” added DeRose.

The Foundation also invests in human capital through its national grant making program, which has distributed more than $49 million to support employment initiatives that promote inclusion of people with disabilities. “We focus our grant making on programs that offer equal access to employment as specified in the ADA,” noted Elaine E. Katz, MS, CCC-SLP, senior vice president of the Foundation’s Center for Grant making and Communications. “Investing in innovative business models that provide competitive jobs for people with disabilities sets an example of what can be achieved when we prioritize workplaces that are diverse and inclusive.”

Workplace inclusion is fundamental to the mission of the Foundation, which views employment as the cornerstone of independence for people with disabilities. In partnership with the University of New Hampshire, the Foundation has funded a series of national surveys on disability and employment that are dispelling long held myths about the aspirations of people with disabilities and their contributions to the post-ADA workplace.

The latest in the series commemorates the ADA’s 30th anniversary – the 2020 Kessler Foundation National Employment and Disability Survey: Recent College Graduates. “This survey provides objective evidence of the progress made by the first generation to come of age in the post-ADA era,” Katz said. “They have successfully navigated the path to higher education, and have transitioned from college to work at the same rate as their peers without disabilities. Clearly, education is the key to employment for all young people, especially for youth with disabilities striving for independence.”

The survey’s topline results were announced in June via a national press release and a well-attended June 3 webinar: “The ADA Generation: New Perspectives on Employment and College Graduates with Disabilities.” A second webinar featuring interviews with three young professionals, “The ADA Generation: A Dialogue with Recent College Graduates with Disabilities,” was held on June 24, to relate the survey’s finding to real-life experiences in college and the workplace. These webinars are available at: https://kesslerfoundation.org/researchcenter-employment-and-disability-researchemployment-and-disability-survey-2020/webinar-2020.

Recent college graduates play a major role in the Foundation’s work, including research, communications, and fundraising. Vicky Queyquep, the Foundation’s donor specialist, shared her college and job search experiences as a person with a disability, culminating in her fulfilling position on the development team. Queyquep’s story illustrates how ADA advances in accessibility and the availability of counseling and support programs contribute to the success of college students with disabilities. Read Queyquep’s story: https://kesslerfoundation.org/info/voices-ada-generation-college-work-story-victoria-queyquep and listen to her podcast: https://soundcloud.com/kesslerfoundation/college-to-work-story-a-young-woman-with-a-disability_vicky-queyquep.

In keeping with the ADA 30 theme, Kessler Foundation is a supporter of “ADA30 Lead On: Celebration of Disability Arts, Culture, Education, and Pride” a star-studded event produced, promoted, and made accessible to all by talented members of the media and entertainment fields, all of whom have disabilities. “We are pleased to join with many of our partners to help support this landmark celebration of disability talent, culture, and pride,” said DeRose. The event, originally scheduled for a live venue in Washington, DC, transitioned to a virtual production when large gatherings were canceled due to the COVID-19 pandemic. ADA Lead On is scheduled to air on Facebook Live and YouTube on July 23, from 7:00-9:15 ET. https://preview.tinyurl.com/y2ez4ruh

“To continue to build on the gains achieved because of the ADA will require renewed commitment as we face the challenges of the coming decade,” DeRose predicted. “Kessler Foundation will continue to be a force for good in the disability community, striving to fulfill the ADA’s promise of “a bright new era of equality, independence and freedom,” he concluded, quoting the words of President George H.W. Bush at the signing of the ADA in 1990.

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research seeking to improve cognition, mobility, and long-term outcomes including employment for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand employment opportunities for people with disabilities.

For more information on Kessler Foundation’s research, visit KesslerFoundation.org

Contact: CMurphy@KesslerFoundation.org; 973-324-8382

Share article on social media or email:

Sanitary Fittings Introduces New Product Line of DIN Fittings


Sanitary Fittings LLC, a distributor of stainless steel fittings and accessories, is introducing a new product line offering of DIN Fittings. The fittings will be available to purchase online in a variety of both length and diameters. All fittings offered by Sanitary Fittings are USDA/FDA approved for use in the food, beverage and pharmaceutical industries.

DIN Fittings are the European counterpart to standard tri-clamp fittings. The food and beverage industries utilize subsets of these fittings including 11851 (threaded style) and 32676 (clamp style). They are primarily used by breweries but can be found in a variety of different industries.

“Occasionally, customers will purchase processing equipment from overseas which typically comes outfitted with DIN Fittings” said co-founder of Sanitary Fittings, John Zabkowicz. “By offering these fittings we can now help customers retrofit equipment without the need for removing existing connections.”

Sanitary Fittings also offers in-house manufacturing capabilities giving customers the option to convert DIN Fittings into tri-clamp fittings by creating custom adapters.

Unlike tri-clamp fittings, DIN Fittings are not 3A Certified. Instead DIN fittings follow the EHEDG (European Hygienic Engineering & Design Group) standard. EHEDG is a non-profit consortium of equipment manufacturers, food producers, suppliers to the food industry dedicated to improving the processes and quality in food production.

For more information about the new DIN fittings product line from Sanitary Fittings, visit https://sanitaryfittings.us, call 800-270-8926, or e-mail your request to john(at)sanitaryfittings.us.

Sanitary Fittings is a leading supplier of stainless steel tube fittings for the food, beverage, and pharmaceutical industries – by offering one of the industry’s most comprehensive product lines available for purchase online.

Share article on social media or email: